The laboratory received a cancer patientslymph node tissue sample for which targeted gene analysis for

CPT® Knowledge Base is a compendium of real life coding questions asked by the coding community and answered by CPT® coding experts.

Over 2900 questions and authoritative answers from the CPT® professionals at the AMA. Get specific answers to challenging coding questions, and search the knowledge base of others' real world questions.

Access to this feature is available in the following products:

AMA's CPT® Advanced Coding Pack

Articles are listed in order of calculated relevance.

May we code for a surgical pathology specimen "recut" when it is medically necessary? For (2006)
May we code for a surgical pathology specimen "recut" when it is medically necessary? For (2006)
A laboratory offers a test that includes multiple different analytes for which analyte-specific codes exist (2012)
What is the rationale behind the addition of Appendix I, new to CPT 2005? (2006)
Our clinic is providing the CA 27.29 antigen test for our patients with stage (2006)
Should codes from the cytogenetics studies series (88271-88275) be used for tissue in situ hybridization (2015)
When should I report code 88358, Morphometric analysis; tumor? (2006)
Our clinic performs an antigen test called CA19-9. For this test, what would be the (2006)
A laboratory performed targeted next-generation sequencing (NGS) on a buccal swab to assess a patient (2021)
It is indicated in the code descriptor that the molecular cytogenetics code (88271) is to (2006)
A patient whose family member carries the BRCA2 gene mutation requested that she also be (2025)
What is the appropriate CPT code to report promoter methylation analysis of BRCA1 and RAD51C (2019)

Thank you for choosing Find-A-Code, please Sign In to remove ads.

MY NEWSLETTERS

FEES

FACILITY

RISK ADJUSTMENT

AMA CPT® Knowledge Base - Apr 1, 2020

Article Overview

Why This Topic Matters

What You Will Learn

Who Should Read This

Codes Discussed

Related Articles